{"id":"https://openalex.org/W2552290902","doi":"https://doi.org/10.3389/fonc.2016.00243","title":"Management of Multiple Myeloma and Usage of Bortezomib: Perspective from India and Ukraine","display_name":"Management of Multiple Myeloma and Usage of Bortezomib: Perspective from India and Ukraine","alternate_titles":[],"publication_year":2016,"publication_date":"2016-11-21","ids":{"openalex":"https://openalex.org/W2552290902","doi":"https://doi.org/10.3389/fonc.2016.00243","mag":"2552290902","pmid":"https://pubmed.ncbi.nlm.nih.gov/27917369","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5117112"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2016.00243","doi":"https://doi.org/10.3389/fonc.2016.00243","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2016.00243","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2016.00243/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2552290902"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2016.00243/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029610349","display_name":"Amit X. Garg","orcid":"https://orcid.org/0000-0002-6599-4910","observed_orcids":["https://orcid.org/0000-0002-6599-4910"]},"institutions":[{"id":"https://openalex.org/I4210117495","display_name":"Dr. Reddy's Laboratories (India)","ror":"https://ror.org/01rkxa860","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210117495"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Amit Garg","raw_affiliation_strings":["Global Medical Affairs, Dr. Reddy\u2019s Laboratories Ltd., Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Dr. Reddy\u2019s Laboratories Ltd., Hyderabad, India","institution_ids":["https://openalex.org/I4210117495"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5096182104","display_name":"Mykhaylo Morgunskyy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mykhaylo Morgunskyy","raw_affiliation_strings":["Global Medical Affairs, Dr. Reddy\u2019s Laboratories Ltd., Kyiv, Ukraine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Dr. Reddy\u2019s Laboratories Ltd., Kyiv, Ukraine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040948491","display_name":"Yogesh R Belagali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117495","display_name":"Dr. Reddy's Laboratories (India)","ror":"https://ror.org/01rkxa860","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210117495"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Yogesh Belagali","raw_affiliation_strings":["Global Medical Affairs, Dr. Reddy\u2019s Laboratories Ltd., Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Dr. Reddy\u2019s Laboratories Ltd., Hyderabad, India","institution_ids":["https://openalex.org/I4210117495"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032835966","display_name":"Namita Gupta","orcid":"https://orcid.org/0000-0002-7422-9276","observed_orcids":["https://orcid.org/0000-0002-7422-9276"]},"institutions":[{"id":"https://openalex.org/I4210117495","display_name":"Dr. Reddy's Laboratories (India)","ror":"https://ror.org/01rkxa860","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210117495"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Namita Gupta","raw_affiliation_strings":["Global Medical Affairs, Dr. Reddy\u2019s Laboratories Ltd., Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Dr. Reddy\u2019s Laboratories Ltd., Hyderabad, India","institution_ids":["https://openalex.org/I4210117495"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005474469","display_name":"Shyam Akku","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117495","display_name":"Dr. Reddy's Laboratories (India)","ror":"https://ror.org/01rkxa860","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210117495"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Shyam Prasad Akku","raw_affiliation_strings":["Global Medical Affairs, Dr. Reddy\u2019s Laboratories Ltd., Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Dr. Reddy\u2019s Laboratories Ltd., Hyderabad, India","institution_ids":["https://openalex.org/I4210117495"]}]},{"author_position":"last","author":{"id":null,"display_name":"India and Ukraine Haemato-oncology Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"India and Ukraine Haemato-oncology Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5005474469"],"corresponding_institution_ids":["https://openalex.org/I4210117495"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"6","issue":null,"first_page":"243","last_page":"243"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":1.0},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9300000071525574},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.9660000205039978},{"id":"https://openalex.org/keywords/stem-cell-transplantation","display_name":"stem cell transplantation","score":0.8090000152587891},{"id":"https://openalex.org/keywords/relapsed-multiple-myeloma","display_name":"relapsed multiple myeloma","score":0.8600000143051147},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.6169999837875366},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.6919999718666077},{"id":"https://openalex.org/keywords/drug-affordability","display_name":"drug affordability","score":0.8519999980926514},{"id":"https://openalex.org/keywords/cost-containment","display_name":"cost containment","score":0.6489999890327454},{"id":"https://openalex.org/keywords/unmet-medical-needs","display_name":"unmet medical needs","score":0.7990000247955322},{"id":"https://openalex.org/keywords/cancer-diagnosis","display_name":"cancer diagnosis","score":0.41200000047683716},{"id":"https://openalex.org/keywords/health-care-access","display_name":"health care access","score":0.6320000290870667},{"id":"https://openalex.org/keywords/india","display_name":"India","score":0.7279999852180481},{"id":"https://openalex.org/keywords/ukraine","display_name":"Ukraine","score":0.8690000176429749},{"id":"https://openalex.org/keywords/pharmacoeconomics","display_name":"pharmacoeconomics","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.8532476425170898},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7394009232521057},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7348429560661316},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.5565784573554993},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.5089612007141113},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.45887529850006104},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4098517596721649},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3886842131614685},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3785322606563568},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3541839122772217},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.09931245446205139},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2016.00243","doi":"https://doi.org/10.3389/fonc.2016.00243","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2016.00243","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2016.00243/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:27917369","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27917369","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5117112","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5117112/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:140751768e4748ed9f39552f57b21bb4","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/140751768e4748ed9f39552f57b21bb4","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 6 (2016)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2016.00243","doi":"https://doi.org/10.3389/fonc.2016.00243","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2016.00243","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2016.00243/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2552290902.pdf","grobid_xml":"https://content.openalex.org/works/W2552290902.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W10535914","https://openalex.org/W132940748","https://openalex.org/W1488767988","https://openalex.org/W1977303037","https://openalex.org/W1986880002","https://openalex.org/W1992981196","https://openalex.org/W2026167391","https://openalex.org/W2055338149","https://openalex.org/W2096207943","https://openalex.org/W2107154392","https://openalex.org/W2108235071","https://openalex.org/W2120529614","https://openalex.org/W2124560610","https://openalex.org/W2127760782","https://openalex.org/W2142368474","https://openalex.org/W2151595053","https://openalex.org/W2156492908","https://openalex.org/W2183499716","https://openalex.org/W2183768906","https://openalex.org/W2294257957","https://openalex.org/W2338119005","https://openalex.org/W2913073599"],"related_works":["https://openalex.org/W7123362266","https://openalex.org/W4392558799","https://openalex.org/W3006659042","https://openalex.org/W24244493","https://openalex.org/W3172584817","https://openalex.org/W2765378545","https://openalex.org/W2913567138","https://openalex.org/W2606102555","https://openalex.org/W4310162948","https://openalex.org/W4392246069"],"abstract_inverted_index":{"Novel":[0],"treatment":[1,214],"strategies":[2],"have":[3],"remarkably":[4],"improved":[5,219],"the":[6,81,105,130,163,245],"multiple":[7],"myeloma":[8],"(MM)":[9],"patients'":[10],"survival,":[11],"with":[12,109],"associated":[13],"increased":[14],"costs.":[15],"A":[16],"joint":[17],"panel":[18],"meet":[19],"of":[20,77,80,104,127,162,175,189,249],"international":[21],"experts":[22],"from":[23],"India":[24,54],"and":[25,45,72,85,100,139,173,205,218,231,238,247],"Ukraine":[26],"was":[27],"held":[28],"in":[29,53,60,160,195,252],"New":[30],"Delhi":[31],"on":[32,37],"May":[33],"19,":[34],"2016":[35],"focusing":[36],"MM":[38],"management,":[39],"bortezomib":[40,110,192],"role,":[41],"unmet":[42],"medical":[43],"needs,":[44],"current":[46],"challenges.":[47],"The":[48,119],"health-care":[49,220,233],"system":[50],"for":[51,129,181],"oncology":[52],"is":[55,124,167,193,202],"majorly":[56],"private":[57],"vs.":[58],"government-based":[59],"Ukraine.":[61],"In":[62,133,187],"India,":[63],"electrophoresis,":[64],"serum-free":[65],"light":[66],"chain":[67],"assays,":[68],"bone":[69,136],"marrow":[70,137],"tests,":[71],"X-rays":[73],"are":[74,107,143,158,179,241],"available":[75],"modes":[76],"diagnosis.":[78],"Despite":[79],"numerous":[82],"cancer":[83],"centers":[84],"stem":[86],"cell":[87],"transplant":[88,95],"centers,":[89],"most":[90,161],"patients":[91,106,115,153],"do":[92],"not":[93],"prefer":[94],"owing":[96],"to":[97,148,170,185,243],"its":[98],"high-cost":[99],"social":[101],"stigma.":[102],"Majority":[103],"treated":[108],"or":[111],"lenalidomide-based":[112],"regimens.":[113],"Most":[114],"buy":[116],"drug":[117],"themselves.":[118],"expanding":[120],"generic":[121],"drugs":[122],"market":[123],"a":[125],"ray":[126],"hope":[128],"affordable":[131,200],"drugs.":[132],"Ukraine,":[134],"immuno-fixation,":[135],"analysis,":[138],"magnetic":[140],"resonance":[141],"imaging":[142],"common":[144,213],"diagnostic":[145],"modalities.":[146],"Due":[147],"high":[149,171],"cost,":[150],"only":[151],"few":[152],"undergo":[154],"transplant.":[155],"Bortezomib-based":[156],"regimens":[157,178],"preferred":[159,194],"patients;":[164],"however,":[165,198],"usage":[166],"limited":[168],"due":[169,184],"costs":[172],"lack":[174],"funds.":[176],"Thalidomide-based":[177],"used":[180],"maintenance":[182],"therapy":[183],"affordability.":[186],"case":[188],"relapsed":[190],"MM,":[191],"triple":[196],"therapy;":[197],"more":[199],"option":[201],"cyclophosphamide,":[203],"thalidomide,":[204],"dexamethasone":[206],"(CTD).":[207],"Issues,":[208],"such":[209],"as":[210],"cost":[211,234],"containment,":[212],"strategies,":[215],"enhanced":[216],"collaboration,":[217],"access,":[221],"need":[222],"immediate":[223],"attention.":[224],"High-quality":[225],"generics":[226],"access":[227],"will":[228],"improve":[229],"outcomes":[230],"support":[232],"containment.":[235],"Pharmacoeconomic":[236],"studies":[237],"head-to-head":[239],"trials":[240],"warranted":[242],"determine":[244],"cost-effectiveness":[246],"benefit":[248],"novel":[250],"therapies":[251],"MM.":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2552290902","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-11-30T00:00:00"}
